Subodh Verma

MD, FRCSC, FAHA, PhD

Scientist, Keenan Research Centre for Biomedical Science

Biography

Please note: Dr. Verma will not take students in summer 2019.

Dr. Subodh Verma is a cardiac surgeon-scientist at St. Michael’s Hospital, Professor at the University of Toronto and the Canada Research Chair in Atherosclerosis. He has been on the India Abroad Power List, recognized as one of Canada’s Top 40 under 40, and honoured with the Howard Morgan Award from the International Academy of Cardiovascular Sciences and the Royal College of Physicians and Surgeons of Canada Gold Medal in Surgery. He is a member of the Royal Society of Canada College of New Scholars, Artists and Scientists, and an inductee of the American Association of Thoracic Surgeons. Dr. Verma runs a practice that encompasses the entire spectrum of adult cardiac surgery (with a special interest in mitral valve repair and bicuspid aortopathy).

He is involved in several clinical trials and oversees a dynamic pre-clinical research laboratory that focuses on the roles of risk factors, inflammation and autophagy in cardiovascular health. His innovative research has culminated in nearly 300 peer-reviewed papers and two United States patents. Dr. Verma’s meta-analysis revealing that bypass surgery is superior to angioplasty in patients with diabetes has been used by the American College of Cardiology and the Canadian Cardiovascular Society (CCS) to shape the recommendations around the best clinical choice for revascularization procedures involving individuals with diabetes. He has contributed to the CCS guidelines for antiplatelet therapy, atrial fibrillation, dyslipidemia, peripheral arterial disease, and stable coronary artery disease; Canadian Cardiovascular Surgery Position Statement and Canadian Cardiometabolic Risk Position Paper. Dr. Verma spearheads the CARDIOLINK platform that will conduct clinical trials in atrial fibrillation, aneurysm and cerebral protection, diabetes and secondary prevention, valvular heart disease, and critical limb ischemia. He (co-)founded and (co-)chairs many regional and national educational initiatives that include the Landmark Lecture, State of the Heart Symposium, Toronto Acute Coronary Syndrome Summit, St. Michael’s Heart Valve Summit, Advances in Cardiology, Current Issues in Cardiology, and At the Heart of Diabetes programs.

 

Recent Publications

  1. Cooper, TT, Hess, DA, Verma, S. Vascular Organoids: Are We Entering a New Area of Cardiometabolic Research?. Cell Metab. 2019;29 (4):792-794. doi: 10.1016/j.cmet.2019.03.008. PubMed PMID:30943391 .
  2. Salata, K, Hussain, MA, Mestral, C, Greco, E, Mamdani, M, Tu, JV et al.. The impact of randomized trial results on abdominal aortic aneurysm repair rates from 2003 to 2016: A population-based time-series analysis. Vascular. 2019; :1708538119829582. doi: 10.1177/1708538119829582. PubMed PMID:30907272 .
  3. Fatehi Hassanabad, A, Feindel, CM, Verma, S, Fedak, PWM. Evolving Surgical Approaches to Bicuspid Aortic Valve Associated Aortopathy. Front Cardiovasc Med. 2019;6 :19. doi: 10.3389/fcvm.2019.00019. PubMed PMID:30886849 PubMed Central PMC6409296.
  4. Verma, S, Wanner, C, Zwiener, I, Ofstad, AP, George, JT, Fitchett, D et al.. Influence of Microvascular Disease on Cardiovascular Events in Type 2 Diabetes. J. Am. Coll. Cardiol. 2019; :. doi: 10.1016/j.jacc.2019.03.002. PubMed PMID:30885684 .
  5. Verma, S, McMurray, JJV. The Serendipitous Story of SGLT2 Inhibitors in Heart Failure: New Insights from DECLARE-TIMI 58. Circulation. 2019; :. doi: 10.1161/CIRCULATIONAHA.119.040514. PubMed PMID:30882236 .
  6. Savarese, G, Sattar, N, Januzzi, J, Verma, S, Lund, LH, Fitchett, D et al.. Empagliflozin Is Associated With a Lower Risk of Post-Acute Heart Failure Rehospitalization and Mortality. Circulation. 2019;139 (11):1458-1460. doi: 10.1161/CIRCULATIONAHA.118.038339. PubMed PMID:30855996 .
  7. AlHamzah, M, Eikelboom, R, Hussain, MA, Syed, MH, Salata, K, Wheatcroft, M et al.. Knowledge gap of peripheral artery disease starts in medical school. J. Vasc. Surg. 2019; :. doi: 10.1016/j.jvs.2018.12.042. PubMed PMID:30852036 .
  8. Verma, S, Bain, SC, Monk Fries, T, Mazer, CD, Nauck, MA, Pratley, RE et al.. Duration of diabetes and cardiorenal efficacy of liraglutide and semaglutide: A post hoc analysis of the LEADER and SUSTAIN 6 clinical trials. Diabetes Obes Metab. 2019; :. doi: 10.1111/dom.13698. PubMed PMID:30851070 .
  9. Terenzi, DC, Al-Omran, M, Quan, A, Teoh, H, Verma, S, Hess, DA et al.. Circulating Pro-Vascular Progenitor Cell Depletion During Type 2 Diabetes: Translational Insights Into the Prevention of Ischemic Complications in Diabetes. JACC Basic Transl Sci. 2019;4 (1):98-112. doi: 10.1016/j.jacbts.2018.10.005. PubMed PMID:30847424 PubMed Central PMC6390504.
  10. Tang, GHL, Verma, S, Bhatt, DL. Two Randomized Clinical Trials on the Treatment of Secondary Mitral Regurgitation-Contradictory or Complementary?. JAMA Cardiol. 2019; :. doi: 10.1001/jamacardio.2019.0204. PubMed PMID:30840036 .
Search PubMed

Affiliations & Other Activities

  • Staff Surgeon, Division of Cardiology , St. Michael’s Hospital
  • Professor, Department of Surgery and Pharmacology & Toxicology, University of Toronto
X